New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AET;RHHBY;MCD;DST;SYT;AKR;ATHN;TSM;MPEL From The Last 14 Days
Check below for free stories on AET;RHHBY;MCD;DST;SYT;AKR;ATHN;TSM;MPEL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 25, 2014
07:32 EDTMCDMcDonald's challenged as younger eaters defect to Chipotle, WSJ says
As McDonald's (MCD) faces a prolonged slump in sales growth, data compiled for The Wall Street Journal by Technomic showed that diners in their 20s and 30s are seeking out fresher, healthier food and defecting to competitors, in particular fast-casual restaurants like Chipotle Mexican Grill (CMG) and higher-end burger chain Five Guys. Reference Link
07:11 EDTRHHBYInterMune volatility expected to move on Roche acquiring for $8.3B
Subscribe for More Information
06:28 EDTTSMTSMC slated to commence 16nm volume production in 1Q15, DigiTimes reports
TSMC (TSM) is expected to start volume production of its 16nm process in 1Q15, DigiTimes reports, citing the Chinese-language Economic Daily News. The company sees monthly output of 50,000 wafers to meet demand for Apple's (AAPL) A9 processors, the report says. Reference Link
August 24, 2014
20:27 EDTRHHBYRoche drops pursuit for remainder of Japan's Chugai, Bloomberg says
Subscribe for More Information
15:41 EDTMCDRussian official says no plans to close McDonald's, Reuters says
The Russian Deputy Prime Minister Arkady Dvorkovich was quoted as saying that there are no plans to close the McDonald's chain in the country, says Reuters. Reference Link
13:41 EDTRHHBYRoche to acquire InterMune for $74.00 per share
Roche (RHHBY) and InterMune (ITMN) announced they have entered into a definitive merger agreement for Roche to fully acquire InterMune at a price of $74.00 per share in an all-cash transaction. This corresponds to a total transaction value of $8.3B on a fully diluted basis. This offer represents a premium of 38% to InterMune's closing price on August 22 and a premium of 63% to InterMune's unaffected closing price on August 12. The merger agreement has been approved by the boards of InterMune and Roche. Under the terms of the merger agreement, Roche will commence a tender offer no later than August 29 to acquire all outstanding shares of InterMune common stock, and InterMune will file a recommendation statement containing the unanimous recommendation of the InterMune board that InterMune's shareholders tender their shares to Roche. The transaction is expected to be neutral to core earnings per share in 2015 and accretive from 2016 onwards. The acquisition of InterMune, a Brisbane, California based biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases, will allow Roche to broaden and strengthen its respiratory portfolio globally. Roche plans a smooth transition of InterMune employees and operations into the Roche organization, ensuring readiness for an expected launch of pirfenidone in the US in 2014. The closing of the transaction is expected to take place in 2014.
August 22, 2014
11:00 EDTMCDRussia continues to push McDonald's with new sanitary checkups, Reuters says
Subscribe for More Information
09:51 EDTMCDMcDonald's brings back Mike Andres with retirement of Jeff Stratton
Subscribe for More Information
August 21, 2014
10:11 EDTTSMTaiwan expects to sell 177M shares of TSMC, Reuters reports
Subscribe for More Information
06:40 EDTMCDMcDonald's looking to expand digital efforts, CNBC says
Subscribe for More Information
August 20, 2014
12:58 EDTMCDMcDonald's temporarily closes certain Russian restaurants
The company said, "Based on a claim from a federal consumer agency, on Aug 20 2014, McDonald’s restaurants on Pushkin Square, Manezh Square and Prospect Mira were temporary closed. We are closely studying the subject of the documents to define what should be done to re-open the restaurants as soon as possible. Our main priority is to serve our customers with top quality menu items. We will continue taking care of our employees and will do our best to continue the success of McDonald’s business in Russia."
August 19, 2014
11:00 EDTMCDMcDonald's to unveil retail coffee initiative, Huffington Post says
Subscribe for More Information
06:02 EDTMCDTaco Bell introducing dollar menu, LA Times reports
Taco Bell (YUM) is introducing its new Dollar Cravings menu, which features 11 items, the LA Times reports. McDonald's (MCD) and Wendy's (WEN) both offer dollar menus. Reference Link
August 18, 2014
06:26 EDTMCDMcDonald's orders products from Thai supplier after food scare, Reuters says
Subscribe for More Information
August 17, 2014
13:40 EDTRHHBYChugai makes statement denying media reports on Roche deal
Subscribe for More Information
August 15, 2014
11:28 EDTRHHBYRoche in talks on $10B deal to buy remainder of Chugai, Bloomberg reports
Roche is in talks to purchase the 38% stake of Chugai Pharmaceutical that it doesn't already own, according to Bloomberg, citing people familiar with the matter. The potential deal is valued at approximately $10B. Though no financial decision has been made, the deal may be announced as early as next week, the sources added. Reference Link
11:02 EDTRHHBYRoche in talk on $10B deal to buy remainder of Chugai, Bloomberg says
Subscribe for More Information
06:39 EDTMCDTim Hortons aims to lure customers via new coffee launch, Reuters says
Tim Hortons (THI) is looking to attract new customers and fight competitors, such as Starbucks (SBUX) and McDonald's (MCD), by revealing a new dark roast coffee blend throughout North America while possibly increasing prices to fend-off increasing expenses and rivals, according to Reuters, citing comments from Tim Hortons CEO Marc Caira. Caira said, "Looking at the coffee market, I would suggest that, given the degree of cost increases, that we are looking at prices going up sometime in 2015." Reference Link
06:16 EDTTSMTSMC Q4 production capacity near fully booked, DigiTimes reports
TSMC has informed Taiwan-based IC design houses that its Q4 production capacity is almost fully booked, reports DigiTimes. According to industry sources, TSMC is urging vendors which are short of production capacity to book wafer orders in advance. Reference Link
06:12 EDTRHHBYGilead announced favorable ruling in arbitration against Roche
Gilead (GILD) announced that an arbitration panel determined that Roche (RHHBY) failed to establish any of their claims and ruled in favor of Gilead. As a result, Roche is not entitled to any damages or other relief. In March 2013, Roche initiated an arbitration against Gilead and Pharmasset, predecessor to Gilead Pharmasset, regarding a 2004 collaboration agreement between Roche and Pharmasset. In the arbitration demand, Roche asserted that it had an exclusive license to sofosbuvir pursuant to the collaboration agreement because sofosbuvir, a prodrug of a uridine monophosphate analog, is allegedly a prodrug of PSI-6130, a cytidine analog. Roche further claimed that, because it had exclusive rights to sofosbuvir, it also had an exclusive license to a patent covering sofosbuvir, and that we infringed that patent by selling and offering for sale products containing sofosbuvir.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use